Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review.
about
Clinical significance of tumor-infiltrating lymphocytes in breast cancerPrecision medicine in breast cancer: reality or utopia?Expression of T-Lymphocyte Markers in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial.Triple negative breast cancer: the kiss of death.A review of the importance of immune responses in luminal B breast cancer.Advancing Immunotherapy in Metastatic Breast Cancer.Biological Subtypes of Triple-Negative Breast Cancer.Role of tumor microenvironment in triple-negative breast cancer and its prognostic significanceGenome-wide identification of key modulators of gene-gene interaction networks in breast cancer.LAG-3+ tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+ tumors.Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer.Immunotherapy for Breast Cancer: What Are We Missing?Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine method.Triple negative breast cancer - prognostic role of immune-related factors: a systematic review.Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer.Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists.Immune Infiltration in Invasive Lobular Breast Cancer.Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in IThe Conundrum of Adjuvant HER2 Treatment Options.Immunotherapeutic interventions of Triple Negative Breast Cancer.Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy.Personalizing Radiation Treatment Delivery in the Management of Breast Cancer.Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapyMagnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancerProfiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification
P2860
Q28070214-1320A599-3D37-416C-850F-4C50811FCF65Q33809114-E9C8FA01-A56D-4529-AC71-6BEAD87404CBQ37547952-043F859A-43BA-4C88-9475-673883A7C83BQ38373249-B17EEF93-CF99-47CB-A72B-37F0DF499726Q38381929-2500CBCB-2DA3-4A2C-B8A6-495F1A0CC742Q38818744-6DFBC5B7-4699-4EEB-A2DB-D0CAC2C08014Q39239484-01C544D8-E781-4971-9923-EDE3CF0E8605Q39324161-67125419-AE6F-4033-B52C-9D013A897B77Q39370768-93578852-A731-46C0-A888-CCFFE08AE8B6Q39449113-AD89B078-EB76-476A-9D64-917372816AC1Q42220629-C6E50C4F-4A15-4256-83A7-B20F0E744506Q42517038-97F6C4FC-C814-43F9-9133-67EFE85E4056Q42690881-2BD826CD-8F8F-4D4D-B578-7BF07B232A1CQ44668850-871FD00C-F95C-4C01-B9CE-B1B4CF3D4C04Q47154705-2447498A-124A-487D-984A-54C202B2C0A2Q47564468-3675B0E1-2F79-4AAE-AC47-030507A1B6B1Q47763725-DDE3FD45-C1AF-4FD6-905A-35DFD259CABFQ47927802-C617C738-1045-453D-8BB7-D9245FE16FB6Q48284336-C7AAAED8-BA2C-402C-BE35-044898B6E87DQ48550627-065D9964-2655-41BB-AE48-DDC908070B04Q50145963-D031178A-83AE-4086-9466-5A188E7D61E6Q50862543-ECA69EEC-61FA-472E-B6AF-F8BFB750F7C1Q54685474-D9BD9234-BA52-4CC7-83CC-983EC42BCCE5Q55216913-33CF4760-FEB7-4028-855C-CE822BE24116Q55257180-570704DC-AC70-4CDA-9102-D51CF2950E97Q55275119-2B2702BC-C49A-4132-AFB8-DFB4349C08A8Q55473791-2B6C79F8-61CD-44A0-ABF4-C59EDDAF1B2FQ57152794-AEBAAA5E-7CC1-47A1-95C6-8842407BA1E2Q58768185-33774D25-BFB6-4861-A299-F2289028AF6AQ58769285-07D9C01C-8F90-4560-94F1-DC0FD71765F7
P2860
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Variation in the Incidence and ...... Subtypes: A Systematic Review.
@ast
Variation in the Incidence and ...... Subtypes: A Systematic Review.
@en
type
label
Variation in the Incidence and ...... Subtypes: A Systematic Review.
@ast
Variation in the Incidence and ...... Subtypes: A Systematic Review.
@en
prefLabel
Variation in the Incidence and ...... Subtypes: A Systematic Review.
@ast
Variation in the Incidence and ...... Subtypes: A Systematic Review.
@en
P1433
P1476
Variation in the Incidence and ...... Subtypes: A Systematic Review.
@en
P2093
Mary L Disis
Sasha E Stanton
P304
P356
10.1001/JAMAONCOL.2016.1061
P50
P577
2016-06-23T00:00:00Z